Ryan J. Ice, Ph.D.
Affiliations: | 2014 | School of Medicine | West Virginia University, Morgantown, WV, United States |
Area:
Oncology, Biochemistry, PharmacologyGoogle:
"Ryan Ice"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Elena N. Pugacheva | grad student | 2014 | West Virginia University | |
| (Implications of NEDD9 on AURKA activity: a biomarker for sensitization and therapeutic target in solid tumors.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Purazo ML, Ice RJ, Shimpi R, et al. (2023) NEDD9 Overexpression Causes Hyperproliferation of Luminal Cells and Cooperates with HER2 Oncogene in Tumor Initiation: A Novel Prognostic Marker in Breast Cancer. Cancers. 15 |
| Sidorov M, Dighe P, Woo RWL, et al. (2023) Dual Targeting of EGFR and MTOR Pathways Inhibits Glioblastoma Growth by Modulating the Tumor Microenvironment. Cells. 12 |
| Chen M, Jian D, Sidorov M, et al. (2022) Pitfalls and Rewards of Setting Up a Liquid Biopsy Approach for the Detection of Driver Mutations in Circulating Tumor DNAs: Our Institutional Experience. Journal of Personalized Medicine. 12 |
| Saqub H, Proetsch-Gugerbauer H, Bezrookove V, et al. (2020) Dinaciclib, a cyclin-dependent kinase inhibitor, suppresses cholangiocarcinoma growth by targeting CDK2/5/9. Scientific Reports. 10: 18489 |
| Pugacheva EN, Kozyreva V, Kiseleva A, et al. (2017) Abstract 1084: Combination of eribulin and AURKA inhibitor prevents metastatic colonization and eradicates established metastases in breast cancer Cancer Research. 77: 1084-1084 |
| Kozyreva VK, Kiseleva A, Ice RJ, et al. (2016) Combination of Eribulin and Aurora A inhibitor MLN8237 prevents metastatic colonization and induces cytotoxic autophagy in breast cancer. Molecular Cancer Therapeutics |
| Ice R, Kiseleva A, Loskutov Y, et al. (2016) Abstract B20: Development of metastatic patient-derived xenografts (PDXs) for accurate assessment of anti-metastatic therapeutics in pre-clinical settings Clinical Cancer Research. 22 |
| Park J, Schlederer M, Schreiber M, et al. (2015) AF1q is a novel TCF7 co-factor which activates CD44 and promotes breast cancer metastasis. Oncotarget |
| Lin CC, Sharma SB, Farrugia MK, et al. (2015) Kruppel-like factor 4 signals through microRNA-206 to promote tumor initiation and cell survival. Oncogenesis. 4: e155 |
| Kozyulina PY, Loskutov YV, Kozyreva VK, et al. (2015) Prometastatic NEDD9 Regulates Individual Cell Migration via Caveolin-1-Dependent Trafficking of Integrins. Molecular Cancer Research : McR. 13: 423-38 |